However, NLRP3 inhibitor (MCC950 sodium) treatment improved cellviability, reduced CASP1 activity, and attenuated IL-1β cytokineproduction during infection, suggesting that NLRP3 inhibitors may be a promisingtherapy against pyroptotic inflammation (407, 408). The gene discussed is NLRP3; the disease is infection.